Introduction The fundamental Difference Between Biosimilar and Biologic Manufacturing from a quality perspective is rooted in the primary objective of […]
Introduction: PLGA Inhalable Microparticle Development combines polymer science, particle engineering, analytical characterization, and inhalation-product performance testing to create a formulation
Introduction Reference Listed Drug (RLD) Sourcing and Reverse Engineering provide the essential scientific and regulatory foundation for Abbreviated New Drug
Reference Listed Drug (RLD) Sourcing and Reverse Engineering: The CDMO’s Role in ANDA Read More »
Introduction The use of Peptide-Oligonucleotide Conjugate (POCs) in CNS Drug Delivery represents an advanced bioconjugation strategy designed to transport therapeutic
Introduction Preparing a Full Characterization Data Package for a GLP-1 Receptor Agonist ANDA is a critical regulatory milestone for demonstrating
Introduction NDSRI Quantification at Ultra-Low Levels requires advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies capable of detecting mutagenic impurities at
Introduction Selecting between Spray Drying vs Solvent Evaporation for poly(lactic-co-glycolic acid) (PLGA) microsphere fabrication requires careful consideration of processing throughput,
Introduction Comprehensive GLP-1 Receptor Agonist Characterization Services for ANDA submissions generate the critical physicochemical, structural, and biological evidence necessary to
Introduction An expert Peptide Mapping Service for Biosimilars offers the analytical infrastructure necessary to verify complete primary amino acid sequence
Introduction A comprehensive Biosimilar Analytical Characterisation Service package delivers a rigorous, multi-tiered, head-to-head comparison of the structural, biophysical, and functional
Biosimilar Analytical Characterization Service: What a Full CRO Package Should Include Read More »
